# Vertex Pharmaceuticals Inc / Ma: Form 8-K, filed May 13, 2026

- Company: [Vertex Pharmaceuticals Inc / Ma](/companies/vrtx.md) (CIK 875320)
- Form: 8-K
- Filed: 2026-05-13
- Accepted by EDGAR: May 13, 2026, 16:03 ET
- Period: 2026-05-13
- Accession: 0000875320-26-000204
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/875320/000087532026000204/vrtx-20260513.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/875320/000087532026000204/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/875320/000087532026000204/vrtx-20260513.htm

Filed May 13, 2026.
Source: SEC EDGAR, the filing index for accession 0000875320-26-000204. Last ingested by Listed: Nov 11, 2026, 01:11 ET. No prices; not investment advice.